Companies / Ayala Pharmaceuticals, Inc.
Ayala Pharmaceuticals, Inc.
ADXSAYLACIK 1797336
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 22, 2021 | Mamluk Roni CEO | Sell Open-market sale | Common Stock | $301.8K | -15K -8.52% | 163,271 | medium |
| Jan 20, 2021 | Mamluk Roni CEO | Sell Open-market sale | Common Stock | $292.5K | -19K -9.77% | 179,877 | medium |
| Feb 24, 2021 | Mamluk Roni CEO | Sell Open-market sale | Common Stock | $187.9K | -11K -6.92% | 145,345 | medium |
| Feb 23, 2021 | Mamluk Roni CEO | Sell Open-market sale | Common Stock | $127.5K | -7K -4.36% | 156,145 | medium |
| Feb 24, 2021 | Gordon Gary B. Executive | Sell Open-market sale | Common Stock | $52.4K | -3K -26.04% | 8,520 | low |
| Jan 20, 2021 | Gordon Gary B. Executive | Sell Open-market sale | Common Stock | $45.1K | -3K -26.04% | 8,520 | low |
| Jan 21, 2021 | Mamluk Roni CEO | Sell Open-market sale | Common Stock | $21.1K | -1K -0.78% | 178,471 | low |
| Feb 24, 2021 | Gordon Gary B. Executive | Exercise Option exercise | Common Stock | $15.5K | +3K +35.21% | 11,520 | low |